Anxiolytic activity of vitex negundo linn. in experimental models of anxiety in mice

International Journal of Green Pharmacy

Volumn 3, Issue 3, 2009, Pages 243-247

  Adnaik, R ^a,b   Pai, P ^a   Sapakal, V ^a   Naikwade, N ^a   Magdum, C ^a  

^a Appasaheb Birnale College of Pharmacy   (India)

^b M Pharm (Pharmacology)   (India)

Author keywords

Anxiolytic; Elevated plus maze; Light dark exploration; Locomotor activity; Vitex negundo

Indexed keywords

DIAZEPAM; VITEX NEGUNDO EXTRACT;

ANIMAL MODEL; ANXIETY; ARTICLE; DRUG EFFECT; LOCOMOTION; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PLANT ROOT; TRANQUILIZING ACTIVITY;

EID: 77953428964     PISSN: 09738258     EISSN: 19984103     Source Type: Journal    
DOI: 10.4103/0973-8258.56284     Document Type: Article

References (43)

1. Barar FSK. Essentials of Pharmacotheraupetics. New Delhi: S. Chand and Company Ltd; 2005. p. 89.
2. Eisenberg RB, Davis SL, Ettner S, Appel S, Wilkey M, Rompay V, et al. Trends in alternative medicine used in United States: Results of a follow up national survey. J Am Med Assoc 1998;280:1569-1575
3. Vogel HG, Vogel WH. Drug discovery and evaluation. Heidelberg, Springer, New York: 2002. p. 401.
4. Satoskar RS, Bhandarkar SD, Rege NN. Pharmacology and Pharmacotheraupetics. 19th ed. Mumbai: Popular Prakashan; 2005. p. 198.
5. Griffiths RR, Sannerud CA. Abuse of and dependence on Benzodiazepines and Other axiolytic/sedative Drugs. Psychopharmacology Services. 3rd ed. New York: Raven Press; 1987. p. 1535-1540
6. Griffiths RR, Ator NA, Roache JD, Lamb RJ. Abuse liability of triazolam: experimental measurements in animals and humans. Psychopharmacological Services. 3rd ed. New York: Raven Press; 1987. . 83-87
7. Wolfman C, Viola H, Paladini A, Dajas F, Medina JH. Possible anxiolytic effects of chrysin: A central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol Biochem Behav 1994;47:1-4.
8. Viola H, Stein ML de, Wolfman C. Apigenin. A component of Matricaria recutita flowers, is a central benzodiazepine receptorligand with anxiolytic effects. Planta Med 1996;61:213-216
9. Salgueiro JB, Ardenghi P, Dias M, Ferreira MB, Izquierdo I, Medina JH. Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacol Biochem Behav 1997;58:887-891
10. Paladini C, Marder M, Viola H, Wolfman C, Wasowski C, Medina JH. Flavonoids and the central nervous system: From forgotten factors to potent anxiolytic compounds. J Pharmacy Pharmacol 1999;51:519-526
11. Dhawan K, Dhawan S, Chhabra S. Attenuation of benzodiazepine dependence in mice by a tri-substituted benzoflavone moiety of Passiflora incarnata Linneaus: A non-habit forming anxiolytic. J Pharma Pharma Sci 2003;6:215-222
12. Heinrich M, Gibbons S. Ethanopharmacology in drug discovery: An analysis of its role and potential contribution. J Pharmacy Pharmacol 53:425-432
13. Beaubrum G, Gray GE. A review of herbal medicines for psychiatric disorders. Psychiatr Serv 2000;51:1130-1134
14. Rex A, Morgenster E, Fink H. Anxiolytic-like effects of kava-kava in the elevated plus maze test-comparison with diazepam. Progr Neuro-Psychopharmacol Biol Psychaitry 2002;26:855-860
15. Friede M, Freudenstein J. Antidepressant and Anxiolytic Effect of St. John's Wort Extract ZE-117. Eur Psychaitry 2002;17:96.
16. Une HD, Sarveiya VP, Pal SC, Kasture VS, Kasture SB. Nootropic and Anxiolytic Activity of Saponins from Albizzia Lebbeck leaves. Pharmacol Biochem Behav 2001;69:439-444
17. Kim WY, Kim JM, Han SB, Lee SK, Kim ND, Park MK, et al. Steaming of ginseng at high temperature enhances biological activity. J Nat Prod 2000;63:1702-1704
18. Anonymous. Directory of Indian Medicinal Plants. Lucknow: CIMAP; 1992. p. 49.
19. Kirtikar KR, Basu BD. Indian Medicinal Plants. 2nd ed. Delhi: Periodicals Experts Book Agency; 1991.
20. Wealth of India. New Delhi: Publication and Information, Council of Scientific and Industrial; 1976. p. 522.
21. Chawla S, Sharma AK, Handa SS, Dhar KL. Chemical investigation and anti-inflammatory activity of Vitex negundo seeds: Part I. Indian J Chem 1991;30:773-776
22. Chawla S, Sharma AK, Handa SS. Chemical investigation and anti-inflammatory activity of Vitex negundo seeds: Part II. J Nat Products 1992;55:163-167
23. Srivastava SC, Sisodia CS. Analgesic studies on Vitex negundo and Valeriana wallichii. Indian Veterinary J 1970;47:170-175
24. Telang RS, Chatterjee S, Varshneya C. Studies on analgesic and antiinflammatory activities of Vitex Negundo Linn. Indian J Pharmacol 1999;31:363-366
25. Gupta M, Majumdar UK, Bhawal SR, Swami SMK. CNS activity of petroleum ether extract of Vitex negundo Linn in mice. Indian J Pharm Sci 1997;59:240-245
26. Tamhankar P, Saraf MN. Antiarthritic activity of Vitex negundo Linn. Indian J Pharm Sci 1994;56:158-161
27. Nair M, Rajagopalan V, Saraf MN. Antiallergic activity of Vitex negundo Linn. Chandigarh: Paper presented at the 46th Indian Pharmaceutical Congress; 1994.
28. Nair M. Studies on the antiallergic activity of Vitex negundo Linn. A thesis submitted to the University of Bombay for the M.Pharm degree 1994.
29. Nair M, Tamhankar CP, Saraf MN. Studies on the mast cell stabilising activity of Vitex negundo Linn. Indian Drugs 1995;32:277-282
30. Dharmasiri MG, Jayakody JR, Galhena G, Liyanage SS, Ratnasooriya WD. Anti-inflammatory and analgesic activities of mature fresh leaves of Vitex negundo. J Ethnopharmacol 2003;87:199-206.
31. Tandon VR, Gupta RK. An experimental evaluation of anticonvulsant activity of Vitex negundo. Indian J Physiol Phamocol 2005;49:199-205.
32. Tandon V, Gupta RK. Vitex negundo Linn (VN) leaf extract as an adjuvant therapy to standard anti-inflammatory drugs. Indian J Med Res 2006;124:447-450
33. Kulkarni SK, Reddy DS. Animal behavioral models for testing antianxiety activity. Met Finds Exp Clin Pharmacol 1996;18:219-240
34. Vogel HG, Vogel WHO. Drug Discovery and Evaluation. Germany: Heidelberg, Springer; 1997. p. 378-379
35. Costall B, Domeney AM, Gerrard PA, Kelly ME, Naylor RJ. Zacopride: Anxiolytic profile in rodent and primate models of anxiety. J Pharmacy Pharmacol 1988;40:302-305
36. Crawley JN, Goodwin FK. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 1981;15:595-599
37. Amborgi LC, Giachetti A. Some factors influencing conditioned and spontaneous behaviour of rats in the light-dark box test. Physiol Behav 1986;36:97-101.
38. Kulkarni SK. Handbook of experimental pharmacology. 3rd ed. New Delhi: Vallabh Prakashan 2005. p. 117-119
39. Dawson GR, Tricklebank MD. Use of the elevated plus maze in search for novel anxiolytic agents. Trends Pharmacol Sci 1995;16:33-36
40. Soderpalm R, Hjorth S, Engel JA. Effects of 5-HTA Receptor agonists and L-5-HTP in montgomery's conflict test. Pharmacol Biochem Behav 1989;32:259-265
41. Treit D. Animal models for the study of anti-anxiety agents: A review. Neurosci Biobehav Rev 1985;9:203-222
42. Lewis JJ. An introduction to pharmacology. London: E. S. Livingstone; 1980. p. 287.
43. Ha JH, Lee DU, Lee JT. 4-hydroxy benzaldehyde from Gasrtrodia elata as active in the antioxidation and GABA ergic neuromodulation of the rat brain. J Ethnopharmacol 2000;73:329-333